KCT0006737尚未招募未知
The usefulness of DPP4 inhibitor among Kidney transplant recipients: a nationwide cohort study
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 18?(Year) 至 99?(Year)（—）
- 性别
- All
入选标准
- •By using specific operation codes and ICD-10 codes, patients extracted from Korean National Health Insurance kidney transplant recipients who received operation between 2002 and 2020.
排除标准
- •patients diagnosed diabetes before transplantation
研究者
相似试验
已完成
不适用
Examination of the usefulness of DPP-4 inhibitor in the treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000011862aka Kinen Clinic10
已完成
4 期
The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium ExcretionType 2 DiabetesNCT02406443University Health Network, Toronto36
已完成
2 期
The effect of sitaglibtin (DPP4 inhibitor) administration in type 2 diabetes patients under insulin therapy regarding the weight, Lipid profile changes and blood glucose controlIRCT20191231045959N2Tabriz University of Medical Sciences60
已完成
不适用
Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000004678Keio University , School of Mecidicine, Department of Internal Medicine50
已完成
不适用
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney diseaseJPRN-UMIN000018464ihon University School of Medicine100